Learn how mutation status may impact mCRC prognoses
BRAF Mutations Can Deepen the Danger in mCRC
Patients with mCRC harboring BRAF V600 mutations exhibit overall survival rates half that of patients with wild-type BRAF 1
Discover the danger of BRAF mutations in mCRC
mCRC, metastatic colorectal cancer.

Reference: 1. Safaee Ardekani G, Jafarnejad SM, Tan L, Saeedi A, Li G. The prognostic value of BRAF mutation in colorectal cancer and melanoma: a systematic review and meta-analysis. PLoS One. 2012;7(10):e47054.
Array Biopharma
Founded on Science, Focused on Patients.
© 2019 Array BioPharma Inc. All rights reserved. NP-US-DE-0036 v1
About Array      Privacy Policy       Legal
This email was sent to amy.gonsuron@amerisourcebergen.com because you have an account with or are a valued partner of ION Solutions. If you no longer wish to receive these types of emails, please click here to unsubscribe or update your email preferences.
AmerisourceBergen - 1300 Morris Dr Chesterbrook PA, 19087
© 2019 ION Solutions. All Rights Reserved.